Medicare Enrolled
Dr. Robert Alter, MD
Hematology · Hackensack, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Alter from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alter?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Alter
Dr. Robert Alter is a hematology specialist in Hackensack, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Alter performed 7,971 Medicare services across 1,358 unique beneficiaries.
Between the years covered by Open Payments, Dr. Alter received a total of $228,550 from 61 pharmaceutical and/or device companies across 990 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Alter is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 32% volume in NJ
$228,550 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,971
Medicare services
Top 32% in NJ for hematology
1,358
Unique beneficiaries
$56
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~399 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
3,930 | $6 | $37 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,205 | $100 | $240 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
952 | $149 | $301 |
| Pegfilgrastim-cbqv injection An injection of pegfilgrastim-cbqv, a biosimilar medication, administered at a dose of 0.5 mg. |
924 | $108 | $785 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
373 | $66 | $154 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
224 | $12 | $72 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
113 | $8 | $33 |
| New patient office visit, complex (60-74 min) | 113 | $173 | $456 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
109 | $139 | $423 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
28 | $6 | $32 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$228,550
Total received (2018-2024)
Avg $32,650/year across 7 years
Top 22% in NJ for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
990
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$122,230 (53.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$85,626 (37.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,694 (9.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$45,799
2023
$25,350
2022
$36,125
2021
$38,722
2020
$31,217
2019
$15,042
2018
$36,295
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$14,795
EMD Serono, Inc.
$11,113
Exelixis Inc.
$8,243
PFIZER INC.
$3,805
Sumitomo Pharma America, Inc.
$2,912
Novartis Pharmaceuticals Corporation
$2,137
Eisai Inc.
$1,797
Janssen Biotech, Inc.
$154
E.R. Squibb & Sons, L.L.C.
$140
Merck Sharp & Dohme LLC
$105
Bayer Healthcare Pharmaceuticals Inc.
$90
Gilead Sciences, Inc.
$78
Apellis Pharmaceuticals, Inc.
$66
Dendreon Pharmaceuticals LLC
$65
AstraZeneca Pharmaceuticals LP
$60
Aveo Pharmaceuticals, Inc.
$54
Celgene Corporation
$46
TAIHO ONCOLOGY, INC.
$37
Pharmacosmos Therapeutics Inc.
$20
SOBI, INC
$19
Daiichi Sankyo Inc.
$19
ABBVIE INC.
$17
GENZYME CORPORATION
$15
Lilly USA, LLC
$14
Top 3 companies account for 74.6% of 2024 payments
All-time payments by company (2018-2024) ›
Bayer HealthCare Pharmaceuticals Inc.
$32,514
EMD Serono, Inc.
$31,704
Astellas Pharma US Inc
$22,069
Exelixis Inc.
$19,813
PFIZER INC.
$19,331
Eisai Inc.
$18,490
EISAI INC.
$16,131
Janssen Biotech, Inc.
$11,684
E.R. Squibb & Sons, L.L.C.
$10,609
Gilead Sciences, Inc.
$7,173
AstraZeneca Pharmaceuticals LP
$6,727
Genentech USA, Inc.
$5,280
Bayer Healthcare Pharmaceuticals Inc.
$4,891
Sumitomo Pharma America, Inc.
$2,925
Regeneron Healthcare Solutions, Inc.
$2,602
PFIZER INTERNATIONAL LLC
$2,473
Novartis Pharmaceuticals Corporation
$2,447
Janssen Scientific Affairs, LLC
$2,422
AVEO Pharmaceuticals, Inc.
$1,643
Myovant Sciences Inc.
$1,057
Blue Earth Diagnostics Limited
$912
Blueprint Medicines Corporation
$881
AstraZeneca UK Limited
$869
Seagen Inc.
$555
Merck Sharp & Dohme LLC
$520
Amgen Inc.
$415
Foundation Medicine, Inc.
$363
GENZYME CORPORATION
$228
Merck Sharp & Dohme Corporation
$216
Dendreon Pharmaceuticals LLC
$138
Daiichi Sankyo Inc.
$131
Collegium Pharmaceutical, Inc.
$105
COMSORT, Inc
$100
Seattle Genetics, Inc.
$100
Janssen Products, LP
$100
Lilly USA, LLC
$95
SANOFI-AVENTIS U.S. LLC
$75
Aveo Pharmaceuticals, Inc.
$74
Celgene Corporation
$73
Apellis Pharmaceuticals, Inc.
$66
Sun Pharmaceutical Industries Inc.
$56
Pharmacosmos Therapeutics Inc.
$53
TOLMAR Pharmaceuticals, Inc.
$47
MEDIVATION FIELD SOLUTIONS LLC
$42
Ipsen Biopharmaceuticals, Inc
$38
TAIHO ONCOLOGY, INC.
$37
Progenics Pharmaceuticals, Inc.
$32
Clovis Oncology, Inc.
$30
Verity Pharmaceuticals Inc.
$29
Janssen Pharmaceuticals, Inc
$26
SOBI, INC
$19
ABBVIE INC.
$17
ARRAY BIOPHARMA INC
$16
Takeda Pharmaceuticals U.S.A., Inc.
$16
Kyowa Kirin, Inc.
$15
Prometheus Laboratories Inc.
$15
SERVIER PHARMACEUTICALS LLC
$14
SUN PHARMACEUTICAL INDUSTRIES INC.
$14
Incyte Corporation
$14
Rigel Pharmaceuticals, Inc.
$13
Fortovia Therapeutics, Inc.
$8
Top 3 companies account for 37.8% of all-time payments
Associated products mentioned in payments ›
AFINITOR · Aliqopa · Aranesp · Axumin · BALVERSA · BAVENCIO · Balversa · Bavencio · CABOMETYX · CALQUENCE · CHANTIX · Cabometyx · DARZALEX · ELIGARD · ELIQUIS · EPKINLY · ERLEADA · Empaveli · Enhertu · Erleada · FOTIVDA · FOUNDATIONONE · Fabhalta · GAVRETO · IMFINZI · INJECTAFER · INLYTA · JADENU · JAKAFI · JEVTANA · KEYTRUDA · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · MONOFERRIC · Morphabond ER · Nplate · Nubeqa · OPDIVO · ORGOVYX · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · PYLARIFY · Padcev · Pomalyst · Proleukin · REBLOZYL · RETEVMO · Rubraca · SANCUSO · SANDOSTATIN · SARCLISA · SOMATULINE DEPOT · SUTENT · Stivarga · TALZENNA · TASIGNA · TECENTRIQ · Tavalisse · Tibsovo · Trelstar · Trodelvy · VERZENIO · VONJO · VOTRIENT · VPRIV · Vanflyta · Vitrakvi · XALKORI · XARELTO · XTAMPZA · XTAMPZAER · XTANDI · Xofigo · Xtampza ER · Xtandi · YONSA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (54%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
Hematologists within 10 mi
132
Per 100K population
13.8
County median income
$123,715
Nearest hospital
HACKENSACK UNIVERSITY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Alter is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Alter experienced with epoetin alfa injection (procrit) for anemia?
Based on Medicare claims data, Dr. Alter performed 3,930 epoetin alfa injection (procrit) for anemia services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Alter receive payments from pharmaceutical companies?
Yes. Dr. Alter received a total of $228,550 from 61 companies across 990 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alter's costs compare to other hematologists in Hackensack?
Dr. Alter's average Medicare payment per service is $56. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alter) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Hackensack
Browse hematologists in Hackensack ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in NJ
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in NJ
Which NJ hematologists receive the most from drug and device companies.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
By company
EMD Serono, Inc. Payments to Doctors
See all physicians who received payments from EMD Serono, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology